Frequencies for first 10,000 rows of indi_pt variable in indi2006q1 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 1 0.01 0.01 ABDOMINAL INFECTION | 3 0.03 0.04 ABDOMINAL PAIN | 11 0.11 0.15 ABDOMINAL PAIN UPPER | 19 0.19 0.34 ABNORMAL BEHAVIOUR | 1 0.01 0.35 ABNORMAL LABOUR | 1 0.01 0.36 ABSCESS | 1 0.01 0.37 ABSCESS INTESTINAL | 2 0.02 0.39 ABSCESS NECK | 1 0.01 0.40 ACARODERMATITIS | 2 0.02 0.42 ACCIDENT | 4 0.04 0.46 ACCIDENT AT WORK | 1 0.01 0.47 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 0.48 ACCIDENTAL EXPOSURE | 11 0.11 0.59 ACIDOSIS | 1 0.01 0.60 ACINETOBACTER INFECTION | 1 0.01 0.61 ACNE | 37 0.37 0.98 ACNE CYSTIC | 1 0.01 0.99 ACQUIRED IMMUNODEFICIENCY SYNDROME | 16 0.16 1.15 ACTINIC KERATOSIS | 1 0.01 1.16 ACUTE CORONARY SYNDROME | 1 0.01 1.17 ACUTE LYMPHOCYTIC LEUKAEMIA | 10 0.10 1.27 ACUTE MYELOID LEUKAEMIA | 58 0.58 1.85 ACUTE MYELOID LEUKAEMIA RECURRENT | 4 0.04 1.89 ACUTE MYOCARDIAL INFARCTION | 46 0.46 2.35 ACUTE PROMYELOCYTIC LEUKAEMIA | 3 0.03 2.38 ACUTE SINUSITIS | 1 0.01 2.39 ACUTE TONSILLITIS | 1 0.01 2.40 ADENOCARCINOMA OF THE CERVIX | 1 0.01 2.41 ADENOCARCINOMA PANCREAS | 5 0.05 2.46 ADULT T-CELL LYMPHOMA/LEUKAEMIA REFRA.. | 5 0.05 2.51 ADVERSE DRUG REACTION | 9 0.09 2.60 ADVERSE EVENT | 2 0.02 2.62 AFFECTIVE DISORDER | 8 0.08 2.70 AGGRESSION | 1 0.01 2.71 AGITATION | 4 0.04 2.75 AKATHISIA | 1 0.01 2.76 ALCOHOL WITHDRAWAL SYNDROME | 2 0.02 2.78 ALCOHOLISM | 4 0.04 2.82 ALLERGIC SINUSITIS | 3 0.03 2.85 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 1 0.01 2.86 ALOPECIA | 4 0.04 2.90 ALVEOLITIS | 1 0.01 2.91 AMAUROSIS FUGAX | 1 0.01 2.92 AMENORRHOEA | 2 0.02 2.94 AMNESIA | 1 0.01 2.95 AMYLOIDOSIS | 1 0.01 2.96 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.97 ANAEMIA | 13 0.13 3.10 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 3.11 ANAEMIA OF MALIGNANT DISEASE | 6 0.06 3.17 ANAESTHESIA | 35 0.35 3.52 ANAL CANCER | 2 0.02 3.54 ANAL CANCER METASTATIC | 2 0.02 3.56 ANALGESIC EFFECT | 12 0.12 3.68 ANALGESIC THERAPY | 2 0.02 3.70 ANGER | 1 0.01 3.71 ANGINA PECTORIS | 34 0.34 4.05 ANGINA UNSTABLE | 1 0.01 4.06 ANGIONEUROTIC OEDEMA | 1 0.01 4.07 ANGIOPLASTY | 4 0.04 4.11 ANKYLOSING SPONDYLITIS | 14 0.14 4.25 ANOREXIA | 1 0.01 4.26 ANTIBIOTIC PROPHYLAXIS | 9 0.09 4.35 ANTICOAGULANT THERAPY | 8 0.08 4.43 ANTIEMETIC SUPPORTIVE CARE | 5 0.05 4.48 ANTIFUNGAL PROPHYLAXIS | 1 0.01 4.49 ANTIINFLAMMATORY THERAPY | 2 0.02 4.51 ANTIPLATELET THERAPY | 1 0.01 4.52 ANTIVIRAL PROPHYLAXIS | 8 0.08 4.60 ANXIETY | 76 0.76 5.36 ANXIETY DISORDER | 5 0.05 5.41 AORTIC THROMBOSIS | 1 0.01 5.42 AORTIC VALVE INCOMPETENCE | 1 0.01 5.43 APLASTIC ANAEMIA | 2 0.02 5.45 ARRHYTHMIA | 6 0.06 5.51 ARRHYTHMIA SUPRAVENTRICULAR | 2 0.02 5.53 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 5.54 ARTERIOSCLEROSIS | 1 0.01 5.55 ARTERIOSCLEROSIS OBLITERANS | 2 0.02 5.57 ARTERITIS | 1 0.01 5.58 ARTHRALGIA | 157 1.57 7.15 ARTHRITIS | 459 4.59 11.74 ARTHRITIS REACTIVE | 1 0.01 11.75 ARTHRODESIS | 1 0.01 11.76 ARTHROGRAM | 1 0.01 11.77 ARTHROPATHY | 5 0.05 11.82 ARTHROPOD BITE | 1 0.01 11.83 ARTHROPOD STING | 3 0.03 11.86 ASCITES | 3 0.03 11.89 ASPERGILLOSIS | 3 0.03 11.92 ASSISTED FERTILISATION | 2 0.02 11.94 ASTHMA | 59 0.59 12.53 ASTROCYTOMA | 2 0.02 12.55 ATRIAL FIBRILLATION | 37 0.37 12.92 ATRIAL FLUTTER | 8 0.08 13.00 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 12 0.12 13.12 AUTISM | 1 0.01 13.13 AUTOIMMUNE DISORDER | 1 0.01 13.14 AUTOIMMUNE HEPATITIS | 1 0.01 13.15 AUTOIMMUNE THYROIDITIS | 2 0.02 13.17 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 7 0.07 13.24 AZOTAEMIA | 1 0.01 13.25 B PRECURSOR TYPE ACUTE LEUKAEMIA | 1 0.01 13.26 B-CELL LYMPHOMA | 10 0.10 13.36 BACK DISORDER | 3 0.03 13.39 BACK INJURY | 8 0.08 13.47 BACK PAIN | 122 1.22 14.69 BACTERAEMIA | 2 0.02 14.71 BACTERIAL INFECTION | 10 0.10 14.81 BASEDOW'S DISEASE | 1 0.01 14.82 BENIGN PROSTATIC HYPERPLASIA | 19 0.19 15.01 BILE DUCT CANCER | 3 0.03 15.04 BILE DUCT OBSTRUCTION | 2 0.02 15.06 BILIARY CIRRHOSIS | 1 0.01 15.07 BILIARY CIRRHOSIS PRIMARY | 2 0.02 15.09 BIPOLAR DISORDER | 38 0.38 15.47 BIPOLAR I DISORDER | 4 0.04 15.51 BIPOLAR II DISORDER | 2 0.02 15.53 BLADDER CANCER | 14 0.14 15.67 BLADDER CANCER RECURRENT | 2 0.02 15.69 BLADDER NEOPLASM | 3 0.03 15.72 BLADDER SPASM | 1 0.01 15.73 BLOOD CALCIUM DECREASED | 1 0.01 15.74 BLOOD CHOLESTEROL | 18 0.18 15.92 BLOOD CHOLESTEROL INCREASED | 90 0.90 16.82 BLOOD CORTISOL DECREASED | 1 0.01 16.83 BLOOD GLUCOSE INCREASED | 1 0.01 16.84 BLOOD HOMOCYSTEINE INCREASED | 1 0.01 16.85 BLOOD IRON | 1 0.01 16.86 BLOOD IRON INCREASED | 2 0.02 16.88 BLOOD PHOSPHORUS INCREASED | 1 0.01 16.89 BLOOD POTASSIUM DECREASED | 2 0.02 16.91 BLOOD PRESSURE | 21 0.21 17.12 BLOOD PRESSURE ABNORMAL | 10 0.10 17.22 BLOOD PRESSURE DECREASED | 1 0.01 17.23 BLOOD PRESSURE INCREASED | 8 0.08 17.31 BLOOD STEM CELL HARVEST | 1 0.01 17.32 BLOOD TESTOSTERONE DECREASED | 3 0.03 17.35 BLOOD TRIGLYCERIDES | 1 0.01 17.36 BLOOD TRIGLYCERIDES INCREASED | 2 0.02 17.38 BODY HEIGHT BELOW NORMAL | 1 0.01 17.39 BONE DISORDER | 1 0.01 17.40 BONE MARROW CONDITIONING REGIMEN | 4 0.04 17.44 BONE MARROW TRANSPLANT | 11 0.11 17.55 BONE MARROW TUMOUR CELL INFILTRATION | 2 0.02 17.57 BONE PAIN | 5 0.05 17.62 BONE SARCOMA | 2 0.02 17.64 BOWEN'S DISEASE | 1 0.01 17.65 BRADYCARDIA | 1 0.01 17.66 BRAIN ABSCESS | 2 0.02 17.68 BRAIN NEOPLASM | 1 0.01 17.69 BREAKTHROUGH PAIN | 2 0.02 17.71 BREAST CANCER | 82 0.82 18.53 BREAST CANCER FEMALE | 1 0.01 18.54 BREAST CANCER IN SITU | 1 0.01 18.55 BREAST CANCER METASTATIC | 30 0.30 18.85 BREAST CANCER STAGE IV | 4 0.04 18.89 BRONCHIECTASIS | 2 0.02 18.91 BRONCHIOLITIS | 2 0.02 18.93 BRONCHITIS | 20 0.20 19.13 BRONCHITIS ACUTE | 5 0.05 19.18 BRONCHITIS CHRONIC | 1 0.01 19.19 BRONCHOPULMONARY ASPERGILLOSIS | 8 0.08 19.27 BURKITT'S LYMPHOMA | 1 0.01 19.28 BURSITIS | 3 0.03 19.31 CAESAREAN SECTION | 1 0.01 19.32 CANCER PAIN | 6 0.06 19.38 CANDIDIASIS | 3 0.03 19.41 CARCINOID TUMOUR | 1 0.01 19.42 CARCINOMA IN SITU OF BLADDER | 1 0.01 19.43 CARDIAC ASSISTANCE DEVICE USER | 2 0.02 19.45 CARDIAC DISORDER | 25 0.25 19.70 CARDIAC FAILURE | 14 0.14 19.84 CARDIAC FAILURE CONGESTIVE | 8 0.08 19.92 CARDIAC FIBRILLATION | 2 0.02 19.94 CARDIAC FLUTTER | 1 0.01 19.95 CARDIAC OPERATION | 2 0.02 19.97 CARDIAC STRESS TEST | 4 0.04 20.01 CARDIAC VALVE DISEASE | 1 0.01 20.02 CARDIOVASCULAR DISORDER | 14 0.14 20.16 CARDIOVASCULAR EVENT PROPHYLAXIS | 2 0.02 20.18 CARPAL TUNNEL SYNDROME | 9 0.09 20.27 CATHETER RELATED COMPLICATION | 2 0.02 20.29 CAUDA EQUINA SYNDROME | 1 0.01 20.30 CELLULITIS | 5 0.05 20.35 CENTRAL NERVOUS SYSTEM NEOPLASM | 1 0.01 20.36 CEREBRAL HAEMORRHAGE | 3 0.03 20.39 CEREBRAL INFARCTION | 9 0.09 20.48 CEREBRAL ISCHAEMIA | 2 0.02 20.50 CEREBROVASCULAR ACCIDENT | 12 0.12 20.62 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 14 0.14 20.76 CEREBROVASCULAR DISORDER | 1 0.01 20.77 CERVICAL ROOT PAIN | 2 0.02 20.79 CERVICOBRACHIAL SYNDROME | 2 0.02 20.81 CERVIX CARCINOMA | 7 0.07 20.88 CHAPPED LIPS | 2 0.02 20.90 CHEMOTHERAPY | 10 0.10 21.00 CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC | 1 0.01 21.01 CHEST INJURY | 1 0.01 21.02 CHEST PAIN | 10 0.10 21.12 CHEST X-RAY ABNORMAL | 1 0.01 21.13 CHOLANGITIS | 1 0.01 21.14 CHOLECYSTITIS | 1 0.01 21.15 CHOLELITHIASIS | 1 0.01 21.16 CHRONIC FATIGUE SYNDROME | 1 0.01 21.17 CHRONIC LYMPHOCYTIC LEUKAEMIA | 3 0.03 21.20 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACT.. | 1 0.01 21.21 CHRONIC MYELOID LEUKAEMIA | 5 0.05 21.26 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 38 0.38 21.64 CHRONIC RESPIRATORY FAILURE | 1 0.01 21.65 CHRONIC SINUSITIS | 1 0.01 21.66 CLOSTRIDIAL INFECTION | 1 0.01 21.67 CLOSTRIDIUM COLITIS | 2 0.02 21.69 COAGULATION TIME | 1 0.01 21.70 COLITIS ULCERATIVE | 7 0.07 21.77 COLON CANCER | 26 0.26 22.03 COLON CANCER METASTATIC | 5 0.05 22.08 COLORECTAL CANCER | 17 0.17 22.25 COLORECTAL CANCER METASTATIC | 11 0.11 22.36 COMPLEX REGIONAL PAIN SYNDROME | 2 0.02 22.38 COMPUTERISED TOMOGRAM | 4 0.04 22.42 COMPUTERISED TOMOGRAM ABDOMEN | 1 0.01 22.43 COMPUTERISED TOMOGRAM THORAX | 1 0.01 22.44 CONNECTIVE TISSUE DISORDER | 1 0.01 22.45 CONSTIPATION | 32 0.32 22.77 CONSTIPATION PROPHYLAXIS | 1 0.01 22.78 CONTRACEPTION | 28 0.28 23.06 CONTUSION | 6 0.06 23.12 CONVULSION | 38 0.38 23.50 CONVULSION PROPHYLAXIS | 4 0.04 23.54 CORNEAL DYSTROPHY | 1 0.01 23.55 CORNEAL TRANSPLANT | 1 0.01 23.56 CORONARY ANGIOPLASTY | 3 0.03 23.59 CORONARY ARTERIAL STENT INSERTION | 6 0.06 23.65 CORONARY ARTERY DISEASE | 13 0.13 23.78 CORONARY ARTERY OCCLUSION | 5 0.05 23.83 CORONARY ARTERY SURGERY | 1 0.01 23.84 CORONARY ARTERY THROMBOSIS | 1 0.01 23.85 COSTOCHONDRITIS | 4 0.04 23.89 COUGH | 17 0.17 24.06 CRANIAL NEUROPATHY | 1 0.01 24.07 CROHN'S DISEASE | 99 0.99 25.06 CROUP INFECTIOUS | 1 0.01 25.07 CULTURE URINE POSITIVE | 1 0.01 25.08 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 25.09 CYSTITIS | 1 0.01 25.10 DEEP VEIN THROMBOSIS | 2 0.02 25.12 DEHYDRATION | 2 0.02 25.14 DELUSION | 1 0.01 25.15 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 2 0.02 25.17 DEMENTIA | 16 0.16 25.33 DEMENTIA ALZHEIMER'S TYPE | 21 0.21 25.54 DENTAL CARE | 1 0.01 25.55 DENTAL PROSTHESIS PLACEMENT | 1 0.01 25.56 DENTAL TREATMENT | 1 0.01 25.57 DEPENDENCE | 2 0.02 25.59 DEPRESSED MOOD | 1 0.01 25.60 DEPRESSION | 222 2.22 27.82 DERMATITIS | 2 0.02 27.84 DERMATITIS ATOPIC | 3 0.03 27.87 DERMATOMYOSITIS | 3 0.03 27.90 DEVICE RELATED INFECTION | 1 0.01 27.91 DIABETES MELLITUS | 142 1.42 29.33 DIABETES MELLITUS INSULIN-DEPENDENT | 16 0.16 29.49 DIABETES MELLITUS MALNUTRITION-RELATED | 2 0.02 29.51 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 49 0.49 30.00 DIABETIC NEPHROPATHY | 2 0.02 30.02 DIABETIC NEUROPATHY | 8 0.08 30.10 DIAGNOSTIC PROCEDURE | 1 0.01 30.11 DIALYSIS | 3 0.03 30.14 DIARRHOEA | 1 0.01 30.15 DIFFICULTY IN WALKING | 1 0.01 30.16 DIFFUSE LARGE B-CELL LYMPHOMA | 8 0.08 30.24 DISCOMFORT | 1 0.01 30.25 DISEASE PROGRESSION | 1 0.01 30.26 DISEASE RECURRENCE | 1 0.01 30.27 DISSEMINATED INTRAVASCULAR COAGULATION | 5 0.05 30.32 DISSEMINATED TUBERCULOSIS | 1 0.01 30.33 DISSOCIATIVE DISORDER | 1 0.01 30.34 DIURETIC EFFECT | 3 0.03 30.37 DIURETIC THERAPY | 3 0.03 30.40 DIZZINESS | 8 0.08 30.48 DRUG ABUSER | 2 0.02 30.50 DRUG DEPENDENCE | 4 0.04 30.54 DRUG EXPOSURE DURING PREGNANCY | 25 0.25 30.79 DRUG INTOLERANCE | 1 0.01 30.80 DRUG RESISTANCE | 1 0.01 30.81 DRUG TOXICITY | 1 0.01 30.82 DRUG USE FOR UNKNOWN INDICATION | 1,323 13.23 44.05 DRUG WITHDRAWAL CONVULSIONS | 1 0.01 44.06 DRUG WITHDRAWAL SYNDROME | 1 0.01 44.07 DRY MOUTH | 2 0.02 44.09 DUODENAL ULCER | 1 0.01 44.10 DYSLIPIDAEMIA | 144 1.44 45.54 DYSMENORRHOEA | 1 0.01 45.55 DYSPEPSIA | 22 0.22 45.77 DYSPHAGIA | 5 0.05 45.82 DYSPNOEA | 6 0.06 45.88 DYSTHYMIC DISORDER | 7 0.07 45.95 DYSURIA | 2 0.02 45.97 EAR DISCOMFORT | 1 0.01 45.98 EAR INFECTION | 3 0.03 46.01 EATING DISORDER | 1 0.01 46.02 ECHOCARDIOGRAM | 1 0.01 46.03 ECZEMA | 5 0.05 46.08 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 1 0.01 46.09 ELECTROLYTE SUBSTITUTION THERAPY | 4 0.04 46.13 EMPHYSEMA | 9 0.09 46.22 ENDOCARDITIS | 3 0.03 46.25 ENDODONTIC PROCEDURE | 1 0.01 46.26 ENDOMETRIAL CANCER | 4 0.04 46.30 ENDOMETRIAL HYPERPLASIA | 1 0.01 46.31 ENDOMETRIOSIS | 4 0.04 46.35 ENDOTHELIAL DYSFUNCTION | 1 0.01 46.36 ENTEROCOCCAL INFECTION | 2 0.02 46.38 ENTEROCOLITIS | 2 0.02 46.40 EPHELIDES | 1 0.01 46.41 EPIDURAL ANAESTHESIA | 3 0.03 46.44 EPILEPSY | 60 0.60 47.04 EPISTAXIS | 1 0.01 47.05 ERECTILE DYSFUNCTION | 57 0.57 47.62 ERYSIPELAS | 3 0.03 47.65 ERYTHRODERMIC PSORIASIS | 2 0.02 47.67 ERYTHROPENIA | 1 0.01 47.68 ESSENTIAL HYPERTENSION | 25 0.25 47.93 EX-SMOKER | 1 0.01 47.94 EXOSTOSIS | 2 0.02 47.96 EXPOSURE TO COMMUNICABLE DISEASE | 1 0.01 47.97 EXTERNAL EAR CELLULITIS | 1 0.01 47.98 EXTRAPYRAMIDAL DISORDER | 1 0.01 47.99 EYE DISORDER | 2 0.02 48.01 EYE INFECTION | 4 0.04 48.05 EYE PAIN | 1 0.01 48.06 EYE PRURITUS | 1 0.01 48.07 EYE SWELLING | 1 0.01 48.08 FABRY'S DISEASE | 5 0.05 48.13 FACET JOINT SYNDROME | 1 0.01 48.14 FALL | 1 0.01 48.15 FAMILIAL RISK FACTOR | 1 0.01 48.16 FATIGUE | 3 0.03 48.19 FEBRILE NEUTROPENIA | 1 0.01 48.20 FEELING ABNORMAL | 2 0.02 48.22 FEELING OF RELAXATION | 1 0.01 48.23 FIBROMYALGIA | 17 0.17 48.40 FIBROSIS | 1 0.01 48.41 FLANK PAIN | 2 0.02 48.43 FLATULENCE | 1 0.01 48.44 FLUID RETENTION | 6 0.06 48.50 FOETAL GROWTH RETARDATION | 1 0.01 48.51 FRACTURE | 2 0.02 48.53 FUNGAL INFECTION | 6 0.06 48.59 GALLBLADDER CANCER | 2 0.02 48.61 GANGRENE | 1 0.01 48.62 GASTRIC CANCER | 24 0.24 48.86 GASTRIC DISORDER | 8 0.08 48.94 GASTRIC PH DECREASED | 1 0.01 48.95 GASTRIC ULCER | 17 0.17 49.12 GASTRITIS | 25 0.25 49.37 GASTROENTERITIS | 10 0.10 49.47 GASTROINTESTINAL CANCER METASTATIC | 1 0.01 49.48 GASTROINTESTINAL DISORDER | 9 0.09 49.57 GASTROINTESTINAL HAEMORRHAGE | 2 0.02 49.59 GASTROINTESTINAL STROMAL TUMOUR | 1 0.01 49.60 GASTROOESOPHAGEAL CANCER | 2 0.02 49.62 GASTROOESOPHAGEAL REFLUX DISEASE | 20 0.20 49.82 GAUCHER'S DISEASE | 3 0.03 49.85 GENERAL ANAESTHESIA | 7 0.07 49.92 GENERALISED ANXIETY DISORDER | 1 0.01 49.93 GERM CELL CANCER | 2 0.02 49.95 GLAUCOMA | 14 0.14 50.09 GLIOBLASTOMA | 3 0.03 50.12 GLIOBLASTOMA MULTIFORME | 7 0.07 50.19 GLOMERULONEPHRITIS CHRONIC | 1 0.01 50.20 GLUCOSE TOLERANCE IMPAIRED | 4 0.04 50.24 GOUT | 16 0.16 50.40 GOUTY ARTHRITIS | 1 0.01 50.41 GRAFT INFECTION | 2 0.02 50.43 GRAND MAL CONVULSION | 1 0.01 50.44 GROWTH HORMONE DEFICIENCY | 7 0.07 50.51 GROWTH RETARDATION | 1 0.01 50.52 GYNAECOLOGICAL EXAMINATION | 1 0.01 50.53 HAEMOGLOBIN DECREASED | 1 0.01 50.54 HAEMORRHAGE | 2 0.02 50.56 HAEMORRHOIDS | 1 0.01 50.57 HALLUCINATION | 1 0.01 50.58 HALLUCINATION, AUDITORY | 1 0.01 50.59 HEAD INJURY | 1 0.01 50.60 HEADACHE | 21 0.21 50.81 HEART RATE | 1 0.01 50.82 HEART RATE INCREASED | 2 0.02 50.84 HEART RATE IRREGULAR | 3 0.03 50.87 HEART VALVE REPLACEMENT | 1 0.01 50.88 HELICOBACTER INFECTION | 10 0.10 50.98 HEMIPLEGIA | 1 0.01 50.99 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 51.00 HEPATIC CIRRHOSIS | 5 0.05 51.05 HEPATIC FUNCTION ABNORMAL | 4 0.04 51.09 HEPATIC NEOPLASM MALIGNANT | 11 0.11 51.20 HEPATITIS B | 11 0.11 51.31 HEPATITIS C | 44 0.44 51.75 HEPATITIS C VIRUS | 3 0.03 51.78 HERNIA REPAIR | 1 0.01 51.79 HERPES SIMPLEX | 2 0.02 51.81 HERPES ZOSTER | 11 0.11 51.92 HIATUS HERNIA | 1 0.01 51.93 HICCUPS | 1 0.01 51.94 HIGH DENSITY LIPOPROTEIN INCREASED | 1 0.01 51.95 HIP ARTHROPLASTY | 3 0.03 51.98 HIP FRACTURE | 2 0.02 52.00 HIV INFECTION | 268 2.68 54.68 HIV TEST POSITIVE | 3 0.03 54.71 HODGKIN'S DISEASE | 9 0.09 54.80 HORMONE LEVEL ABNORMAL | 1 0.01 54.81 HORMONE REPLACEMENT THERAPY | 88 0.88 55.69 HOT FLUSH | 3 0.03 55.72 HYPERCHLORHYDRIA | 1 0.01 55.73 HYPERCHOLESTEROLAEMIA | 28 0.28 56.01 HYPERGLYCAEMIA | 1 0.01 56.02 HYPERHIDROSIS | 3 0.03 56.05 HYPERKALAEMIA | 1 0.01 56.06 HYPERKERATOSIS | 3 0.03 56.09 HYPERLIPIDAEMIA | 42 0.42 56.51 HYPERPARATHYROIDISM SECONDARY | 3 0.03 56.54 HYPERPHOSPHATAEMIA | 9 0.09 56.63 HYPERPROLACTINAEMIA | 1 0.01 56.64 HYPERSENSITIVITY | 17 0.17 56.81 HYPERTENSION | 365 3.65 60.46 HYPERTENSIVE CARDIOMYOPATHY | 2 0.02 60.48 HYPERTENSIVE HEART DISEASE | 3 0.03 60.51 HYPERTHYROIDISM | 3 0.03 60.54 HYPERTONIA | 2 0.02 60.56 HYPERTONIC BLADDER | 7 0.07 60.63 HYPERTRIGLYCERIDAEMIA | 3 0.03 60.66 HYPERURICAEMIA | 6 0.06 60.72 HYPOAESTHESIA | 3 0.03 60.75 HYPOGAMMAGLOBULINAEMIA | 1 0.01 60.76 HYPOKALAEMIA | 3 0.03 60.79 HYPOPITUITARISM | 4 0.04 60.83 HYPOTHYROIDISM | 28 0.28 61.11 HYPOTONIA | 2 0.02 61.13 HYPOVITAMINOSIS | 1 0.01 61.14 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 61.15 ILEUS PARALYTIC | 1 0.01 61.16 ILIAC ARTERY OCCLUSION | 1 0.01 61.17 ILL-DEFINED DISORDER | 280 2.80 63.97 IMMUNISATION | 1 0.01 63.98 IMMUNODEFICIENCY | 1 0.01 63.99 IMMUNOSUPPRESSANT DRUG THERAPY | 6 0.06 64.05 IMPAIRED GASTRIC EMPTYING | 1 0.01 64.06 IN VITRO FERTILISATION | 15 0.15 64.21 INCORRECT DOSE ADMINISTERED | 1 0.01 64.22 INCREASED UPPER AIRWAY SECRETION | 1 0.01 64.23 INDUCTION AND MAINTENANCE OF ANAESTHE.. | 1 0.01 64.24 INDUCTION OF ANAESTHESIA | 1 0.01 64.25 INFECTION | 24 0.24 64.49 INFECTION PROPHYLAXIS | 13 0.13 64.62 INFERTILITY | 2 0.02 64.64 INFERTILITY FEMALE | 6 0.06 64.70 INFESTATION | 1 0.01 64.71 INFILTRATION ANAESTHESIA | 2 0.02 64.73 INFLAMMATION | 12 0.12 64.85 INFLUENZA | 10 0.10 64.95 INFLUENZA LIKE ILLNESS | 2 0.02 64.97 INGUINAL HERNIA REPAIR | 1 0.01 64.98 INITIAL INSOMNIA | 1 0.01 64.99 INSOMNIA | 69 0.69 65.68 INSULIN-REQUIRING TYPE II DIABETES ME.. | 23 0.23 65.91 INTENTIONAL DRUG MISUSE | 8 0.08 65.99 INTENTIONAL OVERDOSE | 3 0.03 66.02 INTERCOSTAL NEURALGIA | 2 0.02 66.04 INTERMITTENT CLAUDICATION | 1 0.01 66.05 INTERSTITIAL LUNG DISEASE | 2 0.02 66.07 INTERVERTEBRAL DISC DEGENERATION | 7 0.07 66.14 INTERVERTEBRAL DISC DISORDER | 1 0.01 66.15 INTERVERTEBRAL DISC OPERATION | 1 0.01 66.16 INTERVERTEBRAL DISC PROTRUSION | 10 0.10 66.26 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 66.27 INTRAOCULAR PRESSURE TEST | 1 0.01 66.28 INTRAVENOUS CATHETER MANAGEMENT | 1 0.01 66.29 INTUBATION | 1 0.01 66.30 INULIN RENAL CLEARANCE | 3 0.03 66.33 IRRITABLE BOWEL SYNDROME | 5 0.05 66.38 ISCHAEMIA | 1 0.01 66.39 ISCHAEMIC CARDIOMYOPATHY | 5 0.05 66.44 JESSNER'S LYMPHOCYTIC INFILTRATION | 2 0.02 66.46 JOINT INJURY | 8 0.08 66.54 JOINT SPRAIN | 1 0.01 66.55 JOINT STIFFNESS | 3 0.03 66.58 JUVENILE ARTHRITIS | 7 0.07 66.65 KERATITIS | 1 0.01 66.66 KIDNEY INFECTION | 1 0.01 66.67 KNEE ARTHROPLASTY | 3 0.03 66.70 KNEE OPERATION | 1 0.01 66.71 LABOUR INDUCTION | 2 0.02 66.73 LACUNAR INFARCTION | 3 0.03 66.76 LARGE CELL LUNG CANCER STAGE IV | 1 0.01 66.77 LARYNGITIS ALLERGIC | 1 0.01 66.78 LEFT VENTRICULAR FAILURE | 2 0.02 66.80 LETHARGY | 1 0.01 66.81 LEUKAEMIA | 6 0.06 66.87 LEUKAEMIA PLASMACYTIC | 2 0.02 66.89 LEUKAEMIA RECURRENT | 1 0.01 66.90 LIBIDO DISORDER | 1 0.01 66.91 LICE INFESTATION | 1 0.01 66.92 LICHEN PLANUS | 1 0.01 66.93 LIGAMENT OPERATION | 1 0.01 66.94 LIMB DISCOMFORT | 2 0.02 66.96 LIMB INJURY | 4 0.04 67.00 LIP AND/OR ORAL CAVITY CANCER | 1 0.01 67.01 LIPID METABOLISM DISORDER | 1 0.01 67.02 LIPIDS INCREASED | 1 0.01 67.03 LIVER DISORDER | 1 0.01 67.04 LIVER TRANSPLANT | 21 0.21 67.25 LOCAL ANAESTHESIA | 10 0.10 67.35 LOSS OF CONSCIOUSNESS | 1 0.01 67.36 LOWER LIMB FRACTURE | 1 0.01 67.37 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 67.40 LUMBAR SPINAL STENOSIS | 1 0.01 67.41 LUMBAR VERTEBRAL FRACTURE | 1 0.01 67.42 LUNG ADENOCARCINOMA | 8 0.08 67.50 LUNG CANCER METASTATIC | 3 0.03 67.53 LUNG DISORDER | 4 0.04 67.57 LUNG INFECTION | 2 0.02 67.59 LUNG INFECTION PSEUDOMONAL | 1 0.01 67.60 LUNG NEOPLASM MALIGNANT | 17 0.17 67.77 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 3 0.03 67.80 LUNG TRANSPLANT | 6 0.06 67.86 LYME DISEASE | 3 0.03 67.89 LYMPHOCYTIC LEUKAEMIA | 1 0.01 67.90 LYMPHOMA | 7 0.07 67.97 MACULAR DEGENERATION | 9 0.09 68.06 MAINTENANCE OF ANAESTHESIA | 4 0.04 68.10 MAJOR DEPRESSION | 14 0.14 68.24 MALAISE | 6 0.06 68.30 MALARIA | 2 0.02 68.32 MALARIA PROPHYLAXIS | 4 0.04 68.36 MALE PATTERN BALDNESS | 1 0.01 68.37 MALIGNANT MELANOMA | 11 0.11 68.48 MALIGNANT MELANOMA STAGE IV | 4 0.04 68.52 MALIGNANT NEOPLASM OF RENAL PELVIS | 4 0.04 68.56 MALNUTRITION | 2 0.02 68.58 MANIA | 5 0.05 68.63 MANTLE CELL LYMPHOMA | 6 0.06 68.69 MEDIASTINAL MASS | 6 0.06 68.75 MEDICAL DIET | 2 0.02 68.77 MEDICAL OBSERVATION | 2 0.02 68.79 MEDULLOBLASTOMA | 3 0.03 68.82 MEMORY IMPAIRMENT | 2 0.02 68.84 MENINGITIS | 5 0.05 68.89 MENINGITIS CRYPTOCOCCAL | 1 0.01 68.90 MENINGITIS ENTEROVIRAL | 2 0.02 68.92 MENISCUS OPERATION | 1 0.01 68.93 MENOMETRORRHAGIA | 1 0.01 68.94 MENOPAUSE | 4 0.04 68.98 MENORRHAGIA | 6 0.06 69.04 MENSTRUAL DISCOMFORT | 1 0.01 69.05 MENSTRUAL DISORDER | 1 0.01 69.06 MENSTRUATION IRREGULAR | 2 0.02 69.08 MENTAL DISORDER | 4 0.04 69.12 MESOTHELIOMA | 3 0.03 69.15 METABOLIC DISORDER | 2 0.02 69.17 METASTASES TO BONE | 34 0.34 69.51 METASTASES TO LIVER | 1 0.01 69.52 METASTASIS | 3 0.03 69.55 METASTATIC BRONCHIAL CARCINOMA | 1 0.01 69.56 METASTATIC MALIGNANT MELANOMA | 4 0.04 69.60 METASTATIC NEOPLASM | 1 0.01 69.61 METASTATIC RENAL CELL CARCINOMA | 4 0.04 69.65 MICTURITION URGENCY | 1 0.01 69.66 MIGRAINE | 32 0.32 69.98 MIGRAINE PROPHYLAXIS | 2 0.02 70.00 MINERAL SUPPLEMENTATION | 2 0.02 70.02 MITRAL VALVE DISEASE | 3 0.03 70.05 MITRAL VALVE PROLAPSE | 1 0.01 70.06 MITRAL VALVE REPLACEMENT | 1 0.01 70.07 MIXED HYPERLIPIDAEMIA | 1 0.01 70.08 MONARTHRITIS | 15 0.15 70.23 MOOD ALTERED | 2 0.02 70.25 MOOD SWINGS | 1 0.01 70.26 MOTION SICKNESS | 1 0.01 70.27 MUCOPOLYSACCHARIDOSIS I | 2 0.02 70.29 MUCOPOLYSACCHARIDOSIS IH | 2 0.02 70.31 MUCOSAL INFLAMMATION | 1 0.01 70.32 MULTIPLE ALLERGIES | 2 0.02 70.34 MULTIPLE MYELOMA | 45 0.45 70.79 MULTIPLE SCLEROSIS | 297 2.97 73.76 MUSCLE INJURY | 1 0.01 73.77 MUSCLE RELAXANT THERAPY | 1 0.01 73.78 MUSCLE SPASMS | 8 0.08 73.86 MUSCLE SPASTICITY | 1 0.01 73.87 MUSCLE STRAIN | 3 0.03 73.90 MUSCULOSKELETAL CHEST PAIN | 1 0.01 73.91 MUSCULOSKELETAL DISORDER | 1 0.01 73.92 MUSCULOSKELETAL PAIN | 8 0.08 74.00 MUSCULOSKELETAL STIFFNESS | 1 0.01 74.01 MYALGIA | 8 0.08 74.09 MYASTHENIA GRAVIS | 3 0.03 74.12 MYCOBACTERIAL INFECTION | 2 0.02 74.14 MYELODYSPLASTIC SYNDROME | 13 0.13 74.27 MYELOPATHY | 1 0.01 74.28 MYOCARDIAL INFARCTION | 22 0.22 74.50 MYOCARDIAL ISCHAEMIA | 16 0.16 74.66 MYOCLONUS | 2 0.02 74.68 MYOPIA | 2 0.02 74.70 MYOSITIS | 1 0.01 74.71 NAIL TINEA | 8 0.08 74.79 NARCOLEPSY | 1 0.01 74.80 NASAL CONGESTION | 2 0.02 74.82 NASOPHARYNGEAL CANCER | 2 0.02 74.84 NASOPHARYNGITIS | 22 0.22 75.06 NAUSEA | 29 0.29 75.35 NECK MASS | 1 0.01 75.36 NECK PAIN | 12 0.12 75.48 NEOPLASM | 4 0.04 75.52 NEOPLASM MALIGNANT | 4 0.04 75.56 NEOPLASM PROPHYLAXIS | 1 0.01 75.57 NEPHROBLASTOMA | 2 0.02 75.59 NEPHROGENIC ANAEMIA | 2 0.02 75.61 NEPHROLITHIASIS | 1 0.01 75.62 NEPHROTIC SYNDROME | 1 0.01 75.63 NERVE INJURY | 1 0.01 75.64 NERVOUS SYSTEM DISORDER | 1 0.01 75.65 NERVOUSNESS | 1 0.01 75.66 NEURALGIA | 14 0.14 75.80 NEUROBLASTOMA | 3 0.03 75.83 NEUROENDOCRINE TUMOUR | 3 0.03 75.86 NEUROPATHY | 20 0.20 76.06 NEUROPATHY PERIPHERAL | 9 0.09 76.15 NEUROSIS | 1 0.01 76.16 NOCARDIOSIS | 2 0.02 76.18 NOCTURIA | 1 0.01 76.19 NON-CARDIAC CHEST PAIN | 1 0.01 76.20 NON-HODGKIN'S LYMPHOMA | 53 0.53 76.73 NON-SMALL CELL LUNG CANCER | 70 0.70 77.43 NON-SMALL CELL LUNG CANCER METASTATIC | 1 0.01 77.44 NON-SMALL CELL LUNG CANCER STAGE IIIB | 2 0.02 77.46 NUTRITIONAL SUPPORT | 6 0.06 77.52 OBESITY | 7 0.07 77.59 OBSESSIVE-COMPULSIVE DISORDER | 3 0.03 77.62 OCULAR HYPERTENSION | 1 0.01 77.63 OEDEMA | 4 0.04 77.67 OEDEMA PERIPHERAL | 4 0.04 77.71 OESOPHAGEAL ADENOCARCINOMA | 1 0.01 77.72 OESOPHAGEAL ADENOCARCINOMA STAGE IV | 1 0.01 77.73 OESOPHAGEAL CANCER METASTATIC | 1 0.01 77.74 OESOPHAGEAL CARCINOMA | 27 0.27 78.01 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 1 0.01 78.02 OESOPHAGITIS | 2 0.02 78.04 OESTROGEN REPLACEMENT THERAPY | 3 0.03 78.07 OLIGODENDROGLIOMA | 2 0.02 78.09 ONYCHOMYCOSIS | 6 0.06 78.15 OPEN ANGLE GLAUCOMA | 1 0.01 78.16 OPEN WOUND | 1 0.01 78.17 OPERATIVE HAEMORRHAGE | 1 0.01 78.18 OPHTHALMOLOGICAL EXAMINATION | 1 0.01 78.19 ORAL CANDIDIASIS | 1 0.01 78.20 ORAL CONTRACEPTION | 5 0.05 78.25 ORAL INFECTION | 1 0.01 78.26 OROPHARYNGEAL CANCER RECURRENT | 1 0.01 78.27 ORTHOSTATIC HYPOTENSION | 1 0.01 78.28 OSTEITIS | 2 0.02 78.30 OSTEOARTHRITIS | 123 1.23 79.53 OSTEOLYSIS | 1 0.01 79.54 OSTEOMYELITIS | 4 0.04 79.58 OSTEOPENIA | 5 0.05 79.63 OSTEOPOROSIS | 94 0.94 80.57 OSTEOPOROSIS POSTMENOPAUSAL | 9 0.09 80.66 OSTEOPOROSIS PROPHYLAXIS | 3 0.03 80.69 OTITIS EXTERNA | 3 0.03 80.72 OTITIS MEDIA | 3 0.03 80.75 OVARIAN CANCER | 18 0.18 80.93 OVARIAN CYST | 1 0.01 80.94 OVARIAN GERM CELL CANCER | 3 0.03 80.97 OVULATION INDUCTION | 1 0.01 80.98 OVULATION PAIN | 1 0.01 80.99 OXYGEN SATURATION DECREASED | 1 0.01 81.00 OXYGEN SUPPLEMENTATION | 1 0.01 81.01 PACEMAKER COMPLICATION | 3 0.03 81.04 PAIN | 228 2.28 83.32 PAIN IN EXTREMITY | 28 0.28 83.60 PAIN MANAGEMENT | 20 0.20 83.80 PALPITATIONS | 2 0.02 83.82 PANCREATIC CARCINOMA | 15 0.15 83.97 PANCREATIC CARCINOMA METASTATIC | 15 0.15 84.12 PANCREATIC CARCINOMA RECURRENT | 1 0.01 84.13 PANCREATIC CARCINOMA STAGE IV | 2 0.02 84.15 PANCREATIC ENZYMES | 1 0.01 84.16 PANCREATITIS | 3 0.03 84.19 PANIC ATTACK | 6 0.06 84.25 PANIC DISORDER | 9 0.09 84.34 PANIC REACTION | 4 0.04 84.38 PARAESTHESIA | 2 0.02 84.40 PARANOIA | 7 0.07 84.47 PARKINSON'S DISEASE | 35 0.35 84.82 PARKINSONISM | 7 0.07 84.89 PATHOGEN RESISTANCE | 2 0.02 84.91 PELVIC PAIN | 1 0.01 84.92 PEMPHIGOID | 1 0.01 84.93 PERIARTHRITIS | 2 0.02 84.95 PERIOPERATIVE ANALGESIA | 1 0.01 84.96 PERIPHERAL CIRCULATORY FAILURE | 1 0.01 84.97 PERIPHERAL VASCULAR DISORDER | 2 0.02 84.99 PERITONEAL CARCINOMA | 2 0.02 85.01 PERITONITIS | 1 0.01 85.02 PERNICIOUS ANAEMIA | 1 0.01 85.03 PETIT MAL EPILEPSY | 3 0.03 85.06 PHARYNGITIS | 2 0.02 85.08 PHARYNGOLARYNGEAL PAIN | 4 0.04 85.12 PHLEBITIS | 2 0.02 85.14 PITUITARY TUMOUR BENIGN | 1 0.01 85.15 PLANTAR FASCIITIS | 3 0.03 85.18 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 85.19 PNEUMONIA | 35 0.35 85.54 PNEUMONIA MYCOPLASMAL | 2 0.02 85.56 PNEUMONIA PNEUMOCOCCAL | 5 0.05 85.61 POLYARTHRITIS | 8 0.08 85.69 POLYDIPSIA | 1 0.01 85.70 POLYMYALGIA RHEUMATICA | 2 0.02 85.72 POLYNEUROPATHY | 1 0.01 85.73 POLYURIA | 3 0.03 85.76 POST HERPETIC NEURALGIA | 1 0.01 85.77 POST POLIO SYNDROME | 1 0.01 85.78 POST PROCEDURAL HAEMORRHAGE | 1 0.01 85.79 POST PROCEDURAL HYPOTHYROIDISM | 1 0.01 85.80 POST PROCEDURAL NAUSEA | 1 0.01 85.81 POST-TRAUMATIC EPILEPSY | 1 0.01 85.82 POST-TRAUMATIC STRESS DISORDER | 3 0.03 85.85 POSTOPERATIVE WOUND INFECTION | 1 0.01 85.86 POSTPARTUM DEPRESSION | 4 0.04 85.90 PRADER-WILLI SYNDROME | 2 0.02 85.92 PRE-ECLAMPSIA | 1 0.01 85.93 PRECOCIOUS PUBERTY | 1 0.01 85.94 PREGNANCY INDUCED HYPERTENSION | 2 0.02 85.96 PREMATURE LABOUR | 4 0.04 86.00 PREMEDICATION | 22 0.22 86.22 PROCEDURAL PAIN | 10 0.10 86.32 PROPHYLACTIC CHEMOTHERAPY | 1 0.01 86.33 PROPHYLAXIS | 103 1.03 87.36 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 11 0.11 87.47 PROPHYLAXIS AGAINST HIV INFECTION | 5 0.05 87.52 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 22 0.22 87.74 PROPHYLAXIS OF NAUSEA AND VOMITING | 9 0.09 87.83 PROSTATE CANCER | 28 0.28 88.11 PROSTATE CANCER METASTATIC | 2 0.02 88.13 PROSTATE CANCER STAGE I | 1 0.01 88.14 PROSTATE CANCER STAGE II | 1 0.01 88.15 PROSTATE EXAMINATION ABNORMAL | 2 0.02 88.17 PROSTATIC ADENOMA | 1 0.01 88.18 PROSTATIC DISORDER | 5 0.05 88.23 PROSTATISM | 1 0.01 88.24 PROSTATITIS | 10 0.10 88.34 PROTEIN S DEFICIENCY | 1 0.01 88.35 PRURITUS | 7 0.07 88.42 PSEUDODEMENTIA | 4 0.04 88.46 PSEUDOMONAS INFECTION | 5 0.05 88.51 PSORIASIS | 24 0.24 88.75 PSORIATIC ARTHROPATHY | 6 0.06 88.81 PSYCHIATRIC SYMPTOM | 4 0.04 88.85 PSYCHOMOTOR RETARDATION | 2 0.02 88.87 PSYCHOTIC DISORDER | 23 0.23 89.10 PULMONARY EMBOLISM | 1 0.01 89.11 PULMONARY FIBROSIS | 1 0.01 89.12 PULMONARY HYPERTENSION | 14 0.14 89.26 PULMONARY OEDEMA | 2 0.02 89.28 PYELONEPHRITIS | 9 0.09 89.37 PYREXIA | 14 0.14 89.51 RADICULOPATHY | 1 0.01 89.52 RASH | 4 0.04 89.56 RECTAL CANCER | 8 0.08 89.64 REFLUX OESOPHAGITIS | 3 0.03 89.67 REFRACTORY ANAEMIA WITH AN EXCESS OF .. | 6 0.06 89.73 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 12 0.12 89.85 RENAL CANCER METASTATIC | 1 0.01 89.86 RENAL DISORDER | 3 0.03 89.89 RENAL DYSPLASIA | 1 0.01 89.90 RENAL FAILURE | 2 0.02 89.92 RENAL FAILURE CHRONIC | 9 0.09 90.01 RENAL IMPAIRMENT | 4 0.04 90.05 RENAL TRANSPLANT | 11 0.11 90.16 RENAL TUBULAR DISORDER | 5 0.05 90.21 RESPIRATORY DISORDER | 1 0.01 90.22 RESPIRATORY MONILIASIS | 1 0.01 90.23 RESPIRATORY TRACT CONGESTION | 1 0.01 90.24 RESPIRATORY TRACT INFECTION | 4 0.04 90.28 RESPIRATORY TRACT INFECTION BACTERIAL | 1 0.01 90.29 RESPIRATORY TRACT INFECTION FUNGAL | 1 0.01 90.30 RESTLESS LEGS SYNDROME | 12 0.12 90.42 RESTLESSNESS | 6 0.06 90.48 RETINAL VEIN OCCLUSION | 1 0.01 90.49 RETINITIS | 2 0.02 90.51 RHEUMATOID ARTHRITIS | 321 3.21 93.72 RHINITIS | 5 0.05 93.77 RHINITIS ALLERGIC | 5 0.05 93.82 RHINORRHOEA | 3 0.03 93.85 RHINOTRACHEITIS | 3 0.03 93.88 RIB FRACTURE | 1 0.01 93.89 ROAD TRAFFIC ACCIDENT | 1 0.01 93.90 ROSACEA | 2 0.02 93.92 ROTATOR CUFF SYNDROME | 8 0.08 94.00 SARCOMA | 8 0.08 94.08 SCHIZOAFFECTIVE DISORDER | 4 0.04 94.12 SCHIZOPHRENIA | 68 0.68 94.80 SCHIZOPHRENIA, PARANOID TYPE | 2 0.02 94.82 SCHIZOPHRENIFORM DISORDER | 2 0.02 94.84 SCIATICA | 10 0.10 94.94 SEASONAL ALLERGY | 6 0.06 95.00 SEBORRHOEIC DERMATITIS | 1 0.01 95.01 SECONDARY HYPERTENSION | 12 0.12 95.13 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 4 0.04 95.17 SEDATION | 4 0.04 95.21 SEDATIVE THERAPY | 5 0.05 95.26 SELF-MEDICATION | 1 0.01 95.27 SENILE PSYCHOSIS | 1 0.01 95.28 SEPSIS | 4 0.04 95.32 SEPSIS SYNDROME | 2 0.02 95.34 SEPTIC SHOCK | 1 0.01 95.35 SERONEGATIVE ARTHRITIS | 1 0.01 95.36 SEXUAL DYSFUNCTION | 1 0.01 95.37 SHOULDER PAIN | 19 0.19 95.56 SIMPLE PARTIAL SEIZURES | 2 0.02 95.58 SINUS CONGESTION | 1 0.01 95.59 SINUS DISORDER | 4 0.04 95.63 SINUS HEADACHE | 1 0.01 95.64 SINUSITIS | 12 0.12 95.76 SJOGREN'S SYNDROME | 2 0.02 95.78 SKIN CHAPPED | 2 0.02 95.80 SKIN DISORDER | 2 0.02 95.82 SKIN IRRITATION | 1 0.01 95.83 SKIN LESION | 1 0.01 95.84 SKIN ULCER | 1 0.01 95.85 SLEEP APNOEA SYNDROME | 2 0.02 95.87 SLEEP DISORDER | 30 0.30 96.17 SLEEP DISORDER THERAPY | 4 0.04 96.21 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 9 0.09 96.30 SMEAR CERVIX | 1 0.01 96.31 SMOKING CESSATION THERAPY | 13 0.13 96.44 SOCIAL PHOBIA | 1 0.01 96.45 SOMATISATION DISORDER | 2 0.02 96.47 SOMNOLENCE | 3 0.03 96.50 SPINAL ANAESTHESIA | 2 0.02 96.52 SPINAL COLUMN STENOSIS | 3 0.03 96.55 SPINAL DISORDER | 1 0.01 96.56 SPINAL FRACTURE | 1 0.01 96.57 SPINAL MYELOGRAM | 1 0.01 96.58 SPINAL OSTEOARTHRITIS | 9 0.09 96.67 SPONDYLITIS | 6 0.06 96.73 SPONDYLOLISTHESIS | 1 0.01 96.74 SPUTUM RETENTION | 2 0.02 96.76 SQUAMOUS CELL CARCINOMA | 8 0.08 96.84 STAPHYLOCOCCAL INFECTION | 2 0.02 96.86 STAPHYLOCOCCAL SEPSIS | 3 0.03 96.89 STATUS ASTHMATICUS | 3 0.03 96.92 STATUS EPILEPTICUS | 1 0.01 96.93 STEM CELL TRANSPLANT | 5 0.05 96.98 STENT PLACEMENT | 8 0.08 97.06 STEVENS-JOHNSON SYNDROME | 1 0.01 97.07 STOMACH DISCOMFORT | 2 0.02 97.09 STOMATITIS | 1 0.01 97.10 STREPTOCOCCAL INFECTION | 6 0.06 97.16 STRESS | 3 0.03 97.19 STRESS INCONTINENCE | 2 0.02 97.21 STRONGYLOIDIASIS | 2 0.02 97.23 SUICIDE ATTEMPT | 13 0.13 97.36 SUPERINFECTION LUNG | 1 0.01 97.37 SWELLING | 2 0.02 97.39 SYNCOPE | 1 0.01 97.40 SYNOVITIS | 1 0.01 97.41 SYSTEMIC ANTIBACTERIAL THERAPY | 1 0.01 97.42 SYSTEMIC ANTIVIRAL TREATMENT | 7 0.07 97.49 SYSTEMIC CANDIDA | 1 0.01 97.50 SYSTEMIC LUPUS ERYTHEMATOSUS | 7 0.07 97.57 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 97.58 T-CELL LYMPHOMA | 4 0.04 97.62 TACHYARRHYTHMIA | 2 0.02 97.64 TACHYCARDIA | 2 0.02 97.66 TAY-SACHS DISEASE | 1 0.01 97.67 TEETHING | 1 0.01 97.68 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 97.69 TENDON DISORDER | 1 0.01 97.70 TENDON RUPTURE | 1 0.01 97.71 TENDONITIS | 4 0.04 97.75 TENSION | 1 0.01 97.76 TESTICULAR MASS | 10 0.10 97.86 TESTIS CANCER | 3 0.03 97.89 THROAT CANCER | 1 0.01 97.90 THROMBOSIS | 6 0.06 97.96 THROMBOSIS PROPHYLAXIS | 15 0.15 98.11 THYMUS DISORDER | 1 0.01 98.12 THYROID CANCER METASTATIC | 2 0.02 98.14 THYROID DISORDER | 7 0.07 98.21 THYROIDECTOMY | 1 0.01 98.22 TINEA BLANCA | 1 0.01 98.23 TINEA INFECTION | 1 0.01 98.24 TINEA PEDIS | 1 0.01 98.25 TOBACCO ABUSE | 1 0.01 98.26 TONSILLITIS | 11 0.11 98.37 TOOTH DISORDER | 2 0.02 98.39 TOOTH EXTRACTION | 1 0.01 98.40 TOOTH INFECTION | 1 0.01 98.41 TOOTHACHE | 7 0.07 98.48 TOURETTE'S DISORDER | 1 0.01 98.49 TRACHEITIS | 3 0.03 98.52 TRACHEOBRONCHITIS | 2 0.02 98.54 TRANSIENT ISCHAEMIC ATTACK | 5 0.05 98.59 TRANSPLANT | 1 0.01 98.60 TRANSPLANT REJECTION | 1 0.01 98.61 TRAUMATIC ARTHRITIS | 1 0.01 98.62 TRAUMATIC HAEMORRHAGE | 1 0.01 98.63 TREMOR | 2 0.02 98.65 TRIGEMINAL NEURALGIA | 9 0.09 98.74 TUBERCULIN TEST POSITIVE | 1 0.01 98.75 TUBERCULOSIS | 1 0.01 98.76 TUBERCULOUS PLEURISY | 5 0.05 98.81 TYPE IIA HYPERLIPIDAEMIA | 2 0.02 98.83 ULCER | 3 0.03 98.86 UNEVALUABLE EVENT | 2 0.02 98.88 UPPER RESPIRATORY TRACT INFECTION | 8 0.08 98.96 URGE INCONTINENCE | 1 0.01 98.97 URINARY INCONTINENCE | 1 0.01 98.98 URINARY RETENTION | 3 0.03 99.01 URINARY TRACT CARCINOMA IN SITU | 1 0.01 99.02 URINARY TRACT INFECTION | 20 0.20 99.22 URTICARIA | 1 0.01 99.23 UTERINE CANCER | 12 0.12 99.35 UTERINE HAEMORRHAGE | 1 0.01 99.36 UTERINE LEIOMYOMA | 3 0.03 99.39 UVEITIS | 7 0.07 99.46 VAGINAL PAIN | 2 0.02 99.48 VAGINITIS BACTERIAL | 1 0.01 99.49 VARICELLA | 2 0.02 99.51 VARICOSE VEIN | 1 0.01 99.52 VASCULAR DEMENTIA | 2 0.02 99.54 VASCULITIS | 1 0.01 99.55 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.56 VENTRICULAR FIBRILLATION | 1 0.01 99.57 VENTRICULAR TACHYCARDIA | 3 0.03 99.60 VERTEBRAL INJURY | 1 0.01 99.61 VERTIGO | 2 0.02 99.63 VIRAL INFECTION | 3 0.03 99.66 VITAMIN B12 DEFICIENCY | 1 0.01 99.67 VITAMIN SUPPLEMENTATION | 7 0.07 99.74 VOMITING | 13 0.13 99.87 WALDENSTROM'S MACROGLOBULINAEMIA | 1 0.01 99.88 WEIGHT DECREASED | 5 0.05 99.93 WHEEZING | 3 0.03 99.96 WHIPLASH INJURY | 1 0.01 99.97 WOLFF-PARKINSON-WHITE SYNDROME | 1 0.01 99.98 WOUND INFECTION | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015